Investigation of the Effectiveness of Acupuncture in Patients Diagnosed With Interstitial Cystitis
Launched by MEDIPOL UNIVERSITY · Jan 22, 2024
Trial Information
Current as of July 12, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is investigating the effectiveness of acupuncture for women diagnosed with interstitial cystitis, a condition that causes bladder pain and frequent urination. The study aims to see if acupuncture can help relieve symptoms and improve the quality of life for these patients. If you are a woman between the ages of 30 and 65 who has been diagnosed with interstitial cystitis and has been experiencing pelvic pain or urinary symptoms for more than six months, you may be eligible to participate.
Participants in this study can expect to receive acupuncture treatment, which involves the insertion of thin needles into specific points on the skin, a practice used for thousands of years in traditional Chinese medicine. The study is currently recruiting participants from February to July 2024, and it is important to note that individuals with certain conditions, such as skin infections or those who have previously had acupuncture, will not be included. This trial could provide valuable information about acupuncture as a potential treatment option for interstitial cystitis.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • who diagnosed IC/BPS
- • between 30-65 years old
- • female
- Exclusion Criteria:
- • Patients who do not meet the IC/BPS diagnostic criteria,
- • who have previously received acupuncture treatment,
- • who have localized skin infections involving the acupuncture areas,
- • who have bleeding diathesis and who use anticoagulant drugs,
- • who cannot comply with the treatment and follow-up schedule will not be included in the study.
About Medipol University
Medipol University is a leading academic institution dedicated to advancing medical research and clinical innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts rigorous clinical trials aimed at improving patient outcomes and enhancing healthcare practices. Leveraging state-of-the-art facilities and a team of experienced researchers and healthcare professionals, Medipol University is committed to contributing to the global medical community through ethical research and the development of novel therapeutic strategies. The institution fosters an environment of academic excellence and integrity, ensuring that all trials adhere to the highest standards of safety and efficacy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Istanbul, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported